Business Context and Reporting Period
This Form 8-K Current Report was filed by vTv Therapeutics Inc. on January 16, 2019. The report details a specific corporate event regarding the unregistered sale of equity securities.
Key Financial Metrics
The filing discloses a capital raise event rather than periodic financial performance metrics.
- Capital Raised: $1.5 million
- Shares Issued: 815,217 shares of Class A common stock
- Price Per Share: $1.84
- Investor: MacAndrews & Forbes Group LLC
The filing text does not provide clear values for revenue, profit, cash flow, margins, debt, or liquidity positions.
Material Changes
On January 16, 2019, the Company exercised its right under a letter agreement dated December 11, 2018, to require the Investor to purchase the aforementioned shares. This transaction resulted in an immediate increase in the Company's cash position and an increase in outstanding Class A common stock.
Guidance, Outlook, and Risks
The filing does not contain management commentary, forward-looking guidance, or specific risk factors beyond the standard disclosure that the transaction details are qualified by reference to the December 2018 Letter Agreement. No unusual items or contingencies were reported in this specific filing.
Investor Verification Checklist
- Verify the terms of the December 2018 Letter Agreement referenced in the filing.
- Confirm the total number of outstanding shares post-transaction.
- Review the Company's subsequent Form 10-K for the year ending December 31, 2018, where the agreement is filed as an exhibit.
- Assess the impact of this capital raise on the Company's runway and dilution to existing shareholders.